Mr. Tom Stern reports

BAUSCH HEALTH'S DERMATOLOGY BUSINESS, ORTHO DERMATOLOGICS, ANNOUNCES THE LAUNCH OF BIAFINE, AN ICONIC FRENCH skin caRE PRODUCT, THROUGH CONVENIENT ONLINE ORDERING

Bausch Health Companies Inc. and its dermatology business Ortho Dermatologics' Biafine Skin Recovery Emulsion is now offered through convenient on-line ordering in the United States. The well-known French skin care formula is available through select on-line channels.

First developed in France in 1971, Biafine is a lightweight emulsion formula designed to support the skin's natural barrier function while helping to maintain skin hydration and comfort. For decades, the formula has been recognized by dermatologists and consumers for its unique texture and versatility in skin care routines. The renowned formulation is gentle enough for sensitive skin, helps soothe skin and is clinically proven to support the skin barrier. Its versatility in skin care routines has contributed to Biafine's recognition among dermatologists and consumers alike.

Tom Stern, vice-president and general manager of the Ortho Dermatologics business, reflected, "We are proud to offer dermatology practices and patients access to a formula that has earned the trust of both professionals and consumers for decades."

Biafine is available directly to patients through select on-line channels, including Amazon. Dermatology practices can provide the product through the Ortho Dermatologics Direct platform which supports in-office access when a dermatologist recommends it as part of a skin care regimen.

About Biafine

Biafine is a French-developed skin care emulsion introduced in 1971, designed to support the skin's natural barrier function while maintaining hydration and comfort. For decades, the formula has been recognized by dermatologists and consumers for its unique texture and versatility in skin care routines. Biafine is offered in the United States as a cosmetic for skin care.

About Bausch Health Companies Inc.

Bausch Health Companies is a global, diversified pharmaceutical company enriching lives through the company's relentless drive to deliver better health outcomes. The company develops, manufactures and markets a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through the company's controlling interest in Bausch + Lomb Corp. The company's ambition is to be a globally integrated health care company, trusted and valued by patients, HCPs, employees and investors. Bausch's dermatology business, Ortho Dermatologics is one of the largest prescription and aesthetic dermatology businesses dedicated to helping patients in the treatment of a range of conditions, including psoriasis, onychomycosis, actinic keratosis, acne, atopic dermatitis and other dermatoses.